Cargando…

The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis

Background: Alzheimer's disease (AD) diagnoses once depended on neuropathologic examination. Now, many widely used, validated biomarkers benefits for monitoring of AD neuropathologic changes. Exosome-derived biomarker studies have reported them to be significantly related to AD's early occ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Wenmin, Gao, Wenyan, Lv, Xiaoling, Xu, Xiaogang, Zhang, Zhongshan, Yan, Jing, Mao, Genxiang, Bu, Zhibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957006/ https://www.ncbi.nlm.nih.gov/pubmed/33732139 http://dx.doi.org/10.3389/fnagi.2021.637218

Ejemplares similares

Neurofilament light chain level in traumatic brain injury: A system review and meta-analysis
por: Gao, Wenyan, et al.
Publicado: (2020)

Dietary flavonoids intake contributes to delay biological aging process: analysis from NHANES dataset
por: Xing, Wenmin, et al.
Publicado: (2023)

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xing, Wenmin, et al.
Publicado: (2022)

The association between dietary intake of flavonoids and its subclasses and the risk of metabolic syndrome
por: Zhao, Zhenlei, et al.
Publicado: (2023)

Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis
por: Dong, Xiaoyan, et al.
Publicado: (2020)

Exosomes Derived From Senescent Cells Promote Cellular Senescence
por: Mao, Genxiang, et al.
Publicado: (2020)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

Association between probiotic, prebiotic, and yogurt consumption and chronic kidney disease: The NHANES 2010–2020
por: Liu, Xiaoxian, et al.
Publicado: (2022)

Characterization of exosomes derived from IPEC-J2 treated with probiotic Bacillus amyloliquefaciens SC06 and its regulation of macrophage functions
por: Xu, Xiaogang, et al.
Publicado: (2022)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis
por: Lin, Ping, et al.
Publicado: (2022)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Develop a diagnostic tool for dementia using machine learning and non-imaging features
por: Wang, Huan, et al.
Publicado: (2022)

The Differential Diagnostic Value of the Callosal Angle and Evans Index in Mild Cognitive Impairment and Alzheimer's Disease
por: Liu, Mengqi, et al.
Publicado: (2021)

Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
por: Manna, Ida, et al.
Publicado: (2020)

Structural Characterization of Gracilariopsis lemaneiformis Polysaccharide and Its Property in Delaying Cellular Senescence
por: Wang, Xiaomei, et al.
Publicado: (2022)

Meta‐analysis of the diagnostic value of exosomal miR‐21 as a biomarker for the prediction of cancer
por: Liu, Fanglan, et al.
Publicado: (2021)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
por: Wittenberg, Raphael, et al.
Publicado: (2019)

Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment
por: Chen, Bo, et al.
Publicado: (2022)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

P-tau231 as a Diagnostic Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease
por: Chen, Jian-jiao, et al.
Publicado: (2017)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
por: Fornari, Chiara, et al.
Publicado: (2022)

Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease
por: Lad, Eleonora M., et al.
Publicado: (2018)

Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's disease
por: Tao, Rui, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer’s disease and mild cognitive impairment
por: Castellazzi, Massimiliano, et al.
Publicado: (2019)

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
por: Oviedo, Diana C., et al.
Publicado: (2018)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
por: Arenare, Giulia, et al.
Publicado: (2023)

Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
por: Zhao, Aonan, et al.
Publicado: (2022)

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
por: Yin, Qingqing, et al.
Publicado: (2020)

Risk estimation before progression to mild cognitive impairment and Alzheimer’s disease: an AD resemblance atrophy index
por: Zhao, Lei, et al.
Publicado: (2019)

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
por: Apostolova, Liana G., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fd6d2bq3omtui7fo8i1jqt8m1j